Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Fate Therapeutics Inc
About FATE
Fate Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to bringing a pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients. Using its proprietary iPSC product platform, the Company has established a position in creating multiplexed-engineered master iPSC lines and in the manufacture and clinical development of off-the-shelf, iPSC-derived cell products. The Company’s pipeline includes iPSC-derived T-cell and natural killer (NK) cell product candidates, which are selectively designed, incorporate novel synthetic controls of cell function, and are intended to deliver multiple therapeutic mechanisms to patients. Its product candidates under development include FT819, FT522, FT829, FT825, FT836, and others. FT819 is its first iPSC-derived CAR T-cell product candidate. FT522 is its first iPSC-derived CAR NK cell product candidate that incorporates its novel Alloimmune Defense Receptor (ADR) technology.
Find out what a historical investment in Fate Therapeutics Inc would be worth today using our FATE stock calculator.
Market Capitalisation
$204.56M
Price-earnings ratio
-
Dividend yield
0.00%
Volume
2.07M
High today
$1.91
Low today
$1.71
Open price
$1.86
52-week high
$2.47
52-week low
$0.91
Ready to start your investing journey with Stake?
Open an accountHow do I buy FATE shares in Australia?
Buying FATE shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Fate Therapeutics Inc in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in FATE
What is the ticker symbol of Fate Therapeutics Inc?
The ticker symbol for Fate Therapeutics Inc is FATE.
How much is one share of FATE?
One share of FATE is valued at $1.77 as of 16 May 2026.
What is the market capitalisation of Fate Therapeutics Inc FATE?
As of 16 May 2026 Fate Therapeutics Inc has a market cap of $204.56M.
What is the 52-week high for Fate Therapeutics Inc stock?
The Fate Therapeutics Inc 52-week high stock price is $2.47.
What is the 52-week low for Fate Therapeutics Inc stock?
The Fate Therapeutics Inc 52-week low stock price is $0.91.
Can I buy FATE shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy FATE shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in FATE on Stake
- Buy FATE from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of FATE from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
FATE related stocks